Paradigm Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Paradigm Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-19,000	Closed	-$608K	–	858
2016 Q1	$608K	Hold	19,000	–	–	0.11%	191
2015 Q4	$812K	Sell	19,000 -33,700	-64%	-$1.35M	0.14%	132
2015 Q3	$1.86M	Sell	52,700 -6,900	-12%	-$311K	0.24%	130
2015 Q2	$2.74M	Hold	59,600	–	–	0.3%	105
2015 Q1	$2.79M	Buy	59,600 +4,400	+8%	+$175K	0.31%	104
2014 Q4	$1.75M	Buy	+55,200	New	+$1.62M	0.23%	140

Other funds holding IPXL

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Paradigm Asset Management's IPXL Position: Q2 2016 in Review

Paradigm Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2016, closing a stake of 19,000 shares — an estimated $608K sold.

Paradigm Asset Management first reported a position in IPXL in Q4 2014 and held it in 6 quarters. The position peaked at $2.79M in Q1 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q2 2016.

Paradigm Asset Management reported no remaining Impax Laboratories, Inc. position as of Q2 2016 after selling out during the quarter.
Paradigm Asset Management sold 19,000 Impax Laboratories, Inc. shares in Q2 2016, an estimated $608K.
Paradigm Asset Management first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 6 quarters.
Paradigm Asset Management's Impax Laboratories, Inc. position peaked at $2.79M in Q1 2015.
198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2016.

Based on Paradigm Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.